Bayer HealthCare Introduces Seresto, Offering Easy-To-Use Flea and Tick Control for Dogs or Cats that Lasts Eight Months

Sun Jan 20, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

-- Seresto uses an innovative, patented formulation

SHAWNEE, Kan., Jan. 20, 2013 /PRNewswire/ -- Bayer HealthCare LLC Animal Health
Division today announced the launch of Seresto, an effective, eight-month tick
and flea preventive in an innovative collar form, at the North American
Veterinary Conference in  Orlando, Fla.  Seresto offers pet owners the
performance they expect from their monthly topicals, but delivers the active
ingredients in an easy-to-use, convenient collar. And with eight months of
effective protection against fleas and ticks on dogs or cats, Seresto is a long
lasting treatment alternative for pet owners without the hassle of remembering
to apply monthly treatments.  

Seresto features an innovative sustained release technology that allows for a
continuous release of imidacloprid and flumethrin in low concentrations. The
sustained release technology releases small amounts of the active ingredients
from the collar to the hair and skin of the animal, where they are distributed
over the hair and skin surface. As a result, Seresto kills fleas within 24 hours
and ticks within 48 hours after initial application. Reinfesting fleas are
killed within two hours and reinfesting ticks are killed as quickly as six

"No other flea or tick preventive on the market provides eight months of
effective flea and tick protection with only one single application for both
dogs or cats," said  Ian Spinks, President and General Manager, Bayer HealthCare
LLC Animal Health Division,  North America. "Bayer HealthCare Animal Health
wants to be the go-to company for all types of parasiticide products. With
Seresto, we give consumers a new alternative to spot-on topical flea and tick,
and oral flea prevention."

Seresto will be sold in veterinary clinics, pet specialty stores and select
online pet pharmacies beginning on  January 21, 2013  at a suggested retail
price of  $70.

"Consumers seldom hear a product referred to as being 'premium-priced' and
'economical choice,' but Seresto is definitely both," said Spinks. "Seresto's
expected price for pet owners will be  $70  for eight months of effective
protection that averages out to a cost-per-month of less than  $10  per dose,
making it an economical choice for effective flea and tick prevention."  

Getting pets closer to year-round flea and tick protection
The Companion Animal Parasite Council recommends year-round protection against
fleas and ticks. But the truth is, many pet owners live busy lives and tend to
forget to give monthly treatments. Some pet owners stretch treatments for longer
than their labeled duration or only apply treatments during times of the year
when fleas and ticks are most prevalent. This can put their pets at a greater
risk for an infestation by fleas or ticks. Infected ticks can transmit organisms
that can cause diseases, including Lyme disease and Rocky Mountain spotted
fever, and flea infestations can cause serious discomfort for pets. Seresto
kills fleas and repels and kills ticks. If a tick is repelled or killed it
cannot attach to a dog or cat and transmit organisms that may cause disease.

Seresto's eight-month duration is a convenient alternative that avoids the
hassle of remembering to apply monthly treatments, according to  Cristiano von
Simson, DVM, MBA, Director of Veterinary Technical Services at Bayer HealthCare
LLC Animal Health Division,  North America.  

"Seresto was designed with compliance in mind," said Dr.  von Simson. "It may
ease the compliance concerns of veterinarians because they know that their
clients are effectively protecting their pets against flea and tick infestations
for eight months. You can fit it and forget it. Seresto is also a great new
option for tick protection on cats because it is able to both kill and repel

The design of Seresto includes a ratchet-release system and, on the small dog
and cat collars, a pre-determined breaking point. This is important so that in
the unlikely event of a cat or dog being trapped, the pet's own strength is
sufficient to allow for a quick release. Each collar also comes with three
optional reflectors for added visibility at night. Seresto will be available for
cats, for small dogs up to 18 pounds, and for large dogs above 18 pounds.  

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of
health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of
Bayer AG with annual sales of  EUR 17.2 billion  (2011), is one of the world's
leading, innovative companies in the healthcare and medical products industry
and is based in Leverkusen,  Germany. The company combines the global activities
of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.
Bayer HealthCare's aim is to discover, develop, manufacture and market products
that will improve human and animal health worldwide. Bayer HealthCare has a
global workforce of 55,700 employees (Dec 31, 2011) and is represented in more
than 100 countries. Find more information at

Find more information at  

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions
and forecasts made by Bayer Group or subgroup management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation, development
or performance of the company and the estimates given here. These factors
include those discussed in Bayer's public reports which are available on the
Bayer website at The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to future events or

SOURCE  Bayer HealthCare LLC

Staci Gouveia, +1-913-268-2577,, or Lauren Dorsch,
+1-913-268-2747, both of Bayer HealthCare LLC

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.